HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zuzana Gdovinova Selected Research

Zuzana Gdovinova Research Topics

Disease

6Stroke (Strokes)
06/2022 - 11/2015
4Parkinson Disease (Parkinson's Disease)
01/2022 - 12/2011
3Ischemic Stroke
01/2022 - 01/2018
2Fatigue
01/2015 - 01/2008
1Relapsing-Remitting Multiple Sclerosis
09/2022
1Cerebral Small Vessel Diseases
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Parkinsonian Disorders (Parkinsonism)
01/2022
1Ataxia (Dyssynergia)
01/2022
1Fabry Disease (Fabry's Disease)
01/2022
1Myoclonus (Nocturnal Myoclonus)
01/2022
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Primary Ovarian Insufficiency
04/2020
1Cerebellar Ataxia (Dysmetria)
04/2020
1Chorea (Rheumatic Chorea)
04/2020
1Movement Disorders (Movement Disorder)
04/2020
1Optic Atrophy
04/2020
1Polyneuropathies (Polyneuropathy)
04/2020
1Atrial Fibrillation
01/2020
1Neurocognitive Disorders (Clerambault Syndrome)
11/2019
1Neurodevelopmental Disorders
11/2019
1Cerebral Hemorrhage
01/2018
1Pain (Aches)
01/2015
1Sleepiness
12/2011

Drug/Important Bio-Agent (IBA)

24- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
01/2020 - 01/2018
24-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
12/2011 - 01/2008
1Biomarkers (Surrogate Marker)IBA
09/2022
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2022
1Dihydroxyphenylalanine (Dopa)IBA
01/2022
1alpha-Galactosidase (Beano)IBA
01/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1Tuberculin (PPD)IBA
01/2021
1Uric Acid (Urate)IBA
01/2021
1Mitochondrial DNA (mtDNA)IBA
04/2020
1DabigatranFDA Link
01/2020
1Transcription Factors (Transcription Factor)IBA
11/2019
1Proteins (Proteins, Gene)FDA Link
11/2019
1SynucleinsIBA
01/2018
1Tissue Plasminogen Activator (Alteplase)FDA Link
11/2015
1Dopamine (Intropin)FDA LinkGeneric
01/2015
1propylene diquat (PDQ(+))IBA
12/2011

Therapy/Procedure

2Thrombectomy
06/2022 - 01/2020
2Therapeutics
06/2020 - 01/2018
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
06/2022